FDA Inspection 1005604 — Omron (Dalian) Co., Ltd. (Plant 1)
The FDA completed an inspection of Omron (Dalian) Co., Ltd. (Plant 1) on February 23, 2017 in Dalian. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 23, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Dalian (China)